CClinicalTrials.gg
CompletedNCT05808140Updated Dec 19, 2025

Fluorescence Imaging With Indocyanine Green(ICG) in Endoscopic Spinal Surgery

A Phase 1/2 interventional study of Indocyanine Green and Fluorescence imaging in Disc Herniation, sponsored by Zhongnan Hospital. Completed at 1 site in China. Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-12-19.

Sponsored by Zhongnan Hospital · Phase 1/2, Interventional, and Diagnostic

Phase
Phase 1/2
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Study summary

In endoscopic spinal nerve root decompression surgery, the intraoperative nerve exploration is time-consuming and critical. According to statistics, the incidence of nerve root injury under spinal endoscope is 1.8-2.5%. Damage to nerve roots may lead to postoperative sensory retardation and motor weakness, thereby impairing the physical function of patients. A real-time auxiliary intraoperative nerve identification technology is necessary.

In this prospective, open-label, randomized, parallel controlled trial, 40 patients who undergo endoscopic spinal surgery are included. Subjects are randomly divided into control group and low, medium and high Indocyanine green(ICG) preoperative administration experimental group. Standard endoscopic spinal surgery is performed in the control group. Patients in the experimental group received an intravenous injection of ICG before surgery, and a standard endoscopic spinal surgery is performed with the use of a fluoroscopic endoscopic surgical imaging system to assist the surgeon in identifying and protecting the nerve roots.

The main objectives of this experiment are (i) to explore the safety and feasibility of ICG fluorescence imaging to assist in nerve root identification during endoscopic spinal surgery and (ii) the effectiveness of this technique for endoscopic search for nerve roots. The secondary objective is to explore the optimal ICG dosing regimen.

Read the detailed description

With the accelerated pace of the global aging society, the prevalence of degenerative diseases is increasing. At present, spinal degenerative diseases caused by body degeneration have become the most common type. With the continuous deepening of the research on spinal degenerative diseases and the continuous development, update and promotion of minimally invasive surgery technology and instruments, minimally invasive surgery has attracted more and more attention of spine surgeons due to its advantages of rapid recovery, small trauma and fewer complications.

The core of endoscopic spinal surgery is nerve root decompression. The procedure is centered on the nerve roots, which can be damaged with the slightest carelessness. According to statistics, the incidence of nerve root injury under spinal endoscope is 1.8-2.5%. Most of the injuries include the stimulation and edema of the nerve root during the operation, which may lead to postoperative sensory retardation and motor weakness, which will damage the patient's physical function and reduce overall satisfaction. The intraoperative nerve exploration is time-consuming and critical, and the variability of the patient's nerve anatomy will also add difficulties to the operation. A real-time auxiliary intraoperative nerve identification technology is necessary.

With the progress of optical technology, fluorescent-guided surgery has shown considerable prospects in assisting in identifying nerves. Indocyanine green (ICG) is the only fluorophore approved by the US Food and Drug Administration (FDA) for intraoperative near-infrared imaging. It can emit near-infrared light after being irradiated by excitation light, which has the characteristics of high penetration depth, low spontaneous fluorescence and high sensitivity. At present, ICG near-infrared fluorescence imaging has been applied to tumor detection, lymphangiography and vascular perfusion evaluation. In recent years, more and more researchers have paid attention to the application value of ICG fluorescence imaging in neuroimaging. It has been applied to clinical research of thoracic sympathetic ganglion, facial nerve, phrenic nerve and pelvic nerve.

02

Conditions studied

  • Disc Herniation

Keywords

  • Disc Herniation
  • Endoscopy
  • Indocyanine green
  • Near-infrared fluorescence imaging
  • Spinal nerve roots
03

In context

Intervertebral Disc Displacement

477 studies on the registry are indexed under Intervertebral Disc Displacement; 103 are open to participants now.

This study's enrollment of 40 is below the median of 63 across 344 interventional studies indexed under Intervertebral Disc Displacement.

Browse Intervertebral Disc Displacement studies →

Lead sponsor

Zhongnan Hospital is the lead sponsor of 103 studies on the registry; 48 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients diagnosed with lumbar disc herniation based on symptoms and Imaging examination
  • Patients undergo endoscopy spinal surgery for nerve root decompression
  • Patients have no clear contraindications to surgery, and has the ability to understand and act and has informed consent, and can participate in all study follow-up voluntarily and signe a written informed consent form.

Exclusion criteria

Exclusion Criteria:

  • The patients have thyroid related diseases, including autonomous nodules
  • Patients are allergic to iodine or shellfish
  • Patients have ankylosing spondylitis, lumbar instability or bony spinal stenosis
  • Patients have diabetes, vascular related diseases, or abnormal liver and kidney function
  • Difficulty in tolerating anaesthesia
  • Pregnant or lactating women
  • Patients are unable to communicate or do not follow directions
  • The investigators consider the patient unsuitable to participate in this study
05

Study design

Phase
Phase 1 / Phase 2
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • No intervention
    Control group

    Standard endoscopic spinal surgery

  • Experimental
    0.5mg/kg ICG group

    The patients receive 0.5mg/kg ICG intravenous injection before surgery. The search for lumbar nerve roots is performed with the assistance of fluoroscopic endoscopic imaging equipment. And the procedure follows standard endoscopic spinal surgery procedures.

    Drug: Indocyanine Green · Device: Fluorescence imaging

  • Experimental
    1mg/kg ICG group

    The patients receive 1mg/kg ICG intravenous injection before surgery. The search for lumbar nerve roots is performed with the assistance of fluoroscopic endoscopic imaging equipment. And the procedure follows standard endoscopic spinal surgery procedures.

    Drug: Indocyanine Green · Device: Fluorescence imaging

  • Experimental
    2mg/kg ICG group

    The patients receive 2mg/kg ICG intravenous injection before surgery. The search for lumbar nerve roots is performed with the assistance of fluoroscopic endoscopic imaging equipment. And the procedure follows standard endoscopic spinal surgery procedures.

    Drug: Indocyanine Green · Device: Fluorescence imaging

Interventions

  • DrugIndocyanine Green

    Preoperatively, a single dose of intravenous indocyanine green is administered

    Also known as: ICG

  • DeviceFluorescence imaging

    Use of a spinal endoscopic fluorescent imaging system to assist surgeons in identifying and protecting nerve roots intraoperatively

06

What researchers measure

Primary outcomes

  1. Fluorescence imaging rate of nerve roots

    Number of the nerve roots with fluorescent imaging in the experimental group/Total nerve roots in the experimental group×100%

    Time frame: Intraoperative

  2. Fluorescence signal ratio of nerve root to back fluorescence

    Nerve root fluorescence intensity/Background fluorescence intensity

    Time frame: Immediately postoperative

  3. Time taken to find the nerve root endoscopically

    Time from opening the ligamentum flavum to finding the nerve root in spinal endoscopic procedures

    Time frame: Intraoperative

Secondary outcomes

  1. ICG-related adverse reactions

    Time frame: Immediately after ICG administration to 30 min after administration

  2. Visual analogue pain scale (Visual analogue scale, VAS)

    The VAS pain score uses the VAS scale, with end 0 being no pain, graded 1-4 being mild pain, 5-6 being moderate pain, 7-9 being severe pain, and end 10 being unbearable pain. The higher the score, the more severe the pain level.

    Time frame: 1 day before surgery, 1 day after surgery, 1 week after surgery, 1 month after surgery

  3. Oswestry disability index(ODI)

    The ODI score is based on the Oswestry Disability Index questionnaire. The lowest score was 0% and the highest score was 100%, with higher scores indicating more severe functional impairment.

    Time frame: 1 day before surgery, 1 day after surgery, 1 week after surgery, 1 month after surgery

  4. Surgical complications

    Record any surgical complications that occurred in the patient within 1 week after surgery

    Time frame: Within 1 week after surgery

  5. Length of surgery

    Use a timer to record the length of the surgery (accurate to the minute)

    Time frame: From the beginning to the end of the surgery

07

Study locations

1 site
  • Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University
    Wuhan, Hubei 430062, China
08

References and documents

Publications

  • Gokaslan ZL, Telfeian AE, Wang MY. Introduction: Endoscopic spine surgery. Neurosurg Focus. 2016 Feb;40(2):E1. doi: 10.3171/2015.11.FOCUS15597. No abstract available. PubMed 26828878 ↗
  • Fourney DR, Dettori JR, Norvell DC, Dekutoski MB. Does minimal access tubular assisted spine surgery increase or decrease complications in spinal decompression or fusion? Spine (Phila Pa 1976). 2010 Apr 20;35(9 Suppl):S57-65. doi: 10.1097/BRS.0b013e3181d82bb8. PubMed 20407352 ↗
  • Strakowski JA. Ultrasound-Guided Peripheral Nerve Procedures. Phys Med Rehabil Clin N Am. 2016 Aug;27(3):687-715. doi: 10.1016/j.pmr.2016.04.006. Epub 2016 Jun 6. PubMed 27468673 ↗
  • He K, Zhou J, Yang F, Chi C, Li H, Mao Y, Hui B, Wang K, Tian J, Wang J. Near-infrared Intraoperative Imaging of Thoracic Sympathetic Nerves: From Preclinical Study to Clinical Trial. Theranostics. 2018 Jan 1;8(2):304-313. doi: 10.7150/thno.22369. eCollection 2018. PubMed 29290809 ↗
  • Kanno K, Aiko K, Yanai S, Sawada M, Sakate S, Andou M. Clinical use of indocyanine green during nerve-sparing surgery for deep endometriosis. Fertil Steril. 2021 Jul;116(1):269-271. doi: 10.1016/j.fertnstert.2021.03.014. Epub 2021 Apr 8. PubMed 33840452 ↗
  • Chen SC, Wang MC, Wang WH, Lee CC, Yang TF, Lin CF, Wang JT, Liao CH, Chang CC, Chen MH, Shih YH, Hsu SP. Fluorescence-assisted visualization of facial nerve during mastoidectomy: A novel technique for preventing iatrogenic facial paralysis. Auris Nasus Larynx. 2015 Apr;42(2):113-8. doi: 10.1016/j.anl.2014.08.008. Epub 2014 Sep 6. PubMed 25199746 ↗
  • He K, Li P, Zhang Z, Liu J, Liu P, Gong S, Chi C, Liu P, Chen C, Tian J. Intraoperative near-infrared fluorescence imaging can identify pelvic nerves in patients with cervical cancer in real time during radical hysterectomy. Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2929-2937. doi: 10.1007/s00259-022-05686-z. Epub 2022 Mar 1. PubMed 35230489 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05808140
Lead sponsor
Zhongnan Hospital
Responsible party
Yuanlong Xie (Principal Investigator, Zhongnan Hospital) — Principal investigator
First posted
Apr 11, 2023
Start date
Apr 11, 2023
Primary completion
Dec 14, 2025
Completion
Dec 14, 2025
Last update
Dec 19, 2025

Study contacts

Yuanlong Xie, M.D.
principal investigator · Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion